<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Heptodin</title>
	<atom:link href="http://www.tapanray.in/tag/heptodin/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Big Pharma Receives Another Body Blow: Would Indian Slumber End Now?</title>
		<link>http://www.tapanray.in/big-pharma-receives-another-body-blow-would-indian-slumber-end-now/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=big-pharma-receives-another-body-blow-would-indian-slumber-end-now</link>
		<comments>http://www.tapanray.in/big-pharma-receives-another-body-blow-would-indian-slumber-end-now/#comments</comments>
		<pubDate>Mon, 19 May 2014 00:00:59 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[B]]></category>
		<category><![CDATA[big]]></category>
		<category><![CDATA[blow]]></category>
		<category><![CDATA[body]]></category>
		<category><![CDATA[bribery]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[CME]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[Committee]]></category>
		<category><![CDATA[glaxo]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[Heptodin]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[J&J]]></category>
		<category><![CDATA[Mark]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[Modi]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Parliamentary]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[PIL]]></category>
		<category><![CDATA[Planning]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[receives]]></category>
		<category><![CDATA[Reily]]></category>
		<category><![CDATA[rip-off]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[slumber]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Teva]]></category>
		<category><![CDATA[UCPMP]]></category>
		<category><![CDATA[Wake-up]]></category>
		<category><![CDATA[Xinhua]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5407</guid>
		<description><![CDATA[On May 13, 2014, The New York Times reported, while major pharmaceutical companies have been facing increased scrutiny of their marketing practices from governments around the world, last Wednesday the Chinese authorities sent a strong warning to the pharmaceutical industry &#8230; <a href="http://www.tapanray.in/big-pharma-receives-another-body-blow-would-indian-slumber-end-now/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/big-pharma-receives-another-body-blow-would-indian-slumber-end-now/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
